Search results
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 3 hours agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing ...
FDA Roundup: April 30, 2024
WKBN 27 Youngstown· 1 hour agoToday the FDA, in coordination with the U.S. Department of Justice (DOJ), announced that the U.S. Marshals Service seized unauthorized e-cigarette products valued at more ...
US opens COVID vaccine to little kids, shots begin next week
AOL· 22 hours agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 1 day agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market ...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 4 days agoFood and Drug Administration (FDA) is set to issue a decision on the company's respiratory syncytial virus (RSV) vaccine candidate by May 12. Should you...
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 7 days agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 4 days agoFDA Nod for Rare Cancer in Kids: The FDA granted approval to Novartis’ radioligand therapy,...
Tucker Carlson video pitching diabetes cure a deepfake
Politifact· 2 days agoBe wary of Facebook posts claiming to help you avoid health scams. A Facebook video claims to show...
3 Ultra-Yield Dividend Stocks Retirees Can Trust
247wallst.com· 1 day agoDividends are a major part of an investor’s complete return profile. By the same token, retirees don’t want to leave potential returns on the table,...
